Targeting glia for bone cancer pain

References

• Bogduk N. On the definitions and physiology of back pain, referred pain, and radicular pain. Pain. 2009;147(1–3):17–19.
   PubMed Web of Science ®Google Scholar
• Zhou Y-Q, Liu Z, Liu Z-H, et al. Interleukin-6: an emerging regulator of pathological pain. J Neuroinflammation. 2016;13(1):141.
   PubMed Web of Science ®Google Scholar
• Falk S, Dickenson AH. Pain and nociception: mechanisms of cancer-induced bone pain. J Clin Oncol. 2014;32(16):1647–1654.
   PubMed Web of Science ®Google Scholar
• Zhou Y-Q, Gao H-Y, Guan X-H, et al. Chemokines and their receptors: potential therapeutic targets for bone cancer pain. Curr Pharm Des. 2015;21(34):5029–5033.
   PubMed Web of Science ®Google Scholar
• Christo PJ, Mazloomdoost D. Interventional pain treatments for cancer pain. Ann N Y Acad Sci. 2008;1138:299–328.
   PubMed Web of Science ®Google Scholar
• Boland JW, Ziegler L, Boland EG, et al. Is regular systemic opioid analgesia associated with shorter survival in adult patients with cancer? A systematic literature review. Pain. 2015;156(11):2152–2163.
   PubMed Web of Science ®Google Scholar
• Christo PJ, Mazloomdoost D. Cancer pain and analgesia. Ann N Y Acad Sci. 2008;1138:278–298.
   PubMed Web of Science ®Google Scholar
• Paice JA, Ferrell B. The management of cancer pain. CA Cancer J Clin. 2011;61(3):157–182.
   PubMed Web of Science ®Google Scholar
• Geis C, Graulich M, Wissmann A, et al. Evoked pain behavior and spinal glia activation is dependent on tumor necrosis factor receptor 1 and 2 in a mouse model of bone cancer pain. Neuroscience. 2010;169(1):463–474.
   PubMed Web of Science ®Google Scholar
• Lu C, Liu Y, Sun B, et al. Intrathecal injection of JWH-015 attenuates bone cancer pain via time-dependent modification of pro-inflammatory cytokines expression and astrocytes activity in spinal cord. Inflammation. 2015;38(5):1880–1890.
   PubMed Web of Science ®Google Scholar
• Ke CB, He WS, Li CJ, et al. Enhanced SCN7A/Nax expression contributes to bone cancer pain by increasing excitability of neurons in dorsal root ganglion. Neuroscience. 2012;227:80–89.
   PubMed Web of Science ®Google Scholar
• Azevedo FA, Carvalho LR, Grinberg LT, et al. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol. 2009;513(5):532–541.
   PubMed Web of Science ®Google Scholar
• An K, Xu Y, Yang H, et al. Subarachnoid transplantation of immortalized galanin-overexpressing astrocytes attenuates chronic neuropathic pain. Eur J Pain. 2010;14(6):595–601.
   PubMed Web of Science ®Google Scholar
• Xu Y, Tian X-B, An K, et al. Lumbar transplantation of immortalized enkephalin-expressing astrocytes attenuates chronic neuropathic pain. Eur J Pain. 2008;12(4):525–533.
   PubMed Web of Science ®Google Scholar
• Pirttimaki TM, Parri HR. Astrocyte plasticity: implications for synaptic and neuronal activity. Neuroscientist. 2013;19(6):604–615.
   PubMed Web of Science ®Google Scholar
• Chen Z, Trapp BD. Microglia and neuroprotection. J Neurochem. 2016;136(Suppl 1):10–17.
   PubMed Web of Science ®Google Scholar
• Tian X, Wang G, Xu Y, et al. An improved tet-on system for gene expression in neurons delivered by a single lentiviral vector. Hum Gene Ther. 2009;20(2):113–123.
   PubMed Web of Science ®Google Scholar
• Cao F, Chen S-S, Yan X-F, et al. Evaluation of side effects through selective ablation of the mu opioid receptor expressing descending nociceptive facilitatory neurons in the rostral ventromedial medulla with dermorphin-saporin. Neurotoxicology. 2009;30(6):1096–1106.
   PubMed Web of Science ®Google Scholar
• Zhang R-X, Liu B, Wang L, et al. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain. 2005;118(1–2):125–136.
   PubMed Web of Science ®Google Scholar
• Cao F, Gao F, Xu A-J, et al. Regulation of spinal neuroimmune responses by prolonged morphine treatment in a rat model of cancer induced bone pain. Brain Res. 2010;1326:162–173.
   PubMed Web of Science ®Google Scholar
• Ke C, Li C, Huang X, et al. Protocadherin20 promotes excitatory synaptogenesis in dorsal horn and contributes to bone cancer pain. Neuropharmacology. 2013;75:181–190.
   PubMed Web of Science ®Google Scholar
• Ye D, Bu H, Guo G, et al. Activation of CXCL10/CXCR3 signaling attenuates morphine analgesia: involvement of Gi protein. J Mol Neurosci. 2014;53(4):571–579.
   PubMed Web of Science ®Google Scholar
• Song Z-P, Xiong B-R, Guan X-H, et al. Minocycline attenuates bone cancer pain in rats by inhibiting NF-kappaB in spinal astrocytes. Acta Pharmacol Sin. 2016;37(6):753–762.
   PubMed Web of Science ®Google Scholar
• Ke C, Gao F, Tian X, et al. Slit2/Robo1 mediation of synaptic plasticity contributes to bone cancer pain. Mol Neurobiol. 2016. [Epub ahead of print].
   Google Scholar
• Tsuda M, Shigemoto-Mogami Y, Koizumi S, et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature. 2003;424(6950):778–783.
   PubMed Web of Science ®Google Scholar
• Ghilardi JR, Röhrich H, Lindsay TH, et al. Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J Neurosci. 2005;25(12):3126–3131.
   PubMed Web of Science ®Google Scholar
• Halvorson KG, Kubota K, Sevcik MA, et al. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res. 2005;65(20):9426–9435.
   PubMed Web of Science ®Google Scholar
• Luger NM, Honore P, Sabino MA, et al. Osteoprotegerin diminishes advanced bone cancer pain. Cancer Res. 2001;61(10):4038–4047.
   PubMed Web of Science ®Google Scholar
• Currie GL, Delaney A, Bennett MI, et al. Animal models of bone cancer pain: systematic review and meta-analyses. Pain. 2013;154(6):917–926.
   PubMed Web of Science ®Google Scholar
• Mantyh PW, Clohisy DR, Koltzenburg M, et al. Molecular mechanisms of cancer pain. Nat Rev Cancer. 2002;2(3):201–209.
   PubMed Web of Science ®Google Scholar
• Schwei MJ, Honore P, Rogers SD, et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci. 1999;19(24):10886–10897.
   PubMed Web of Science ®Google Scholar
• Honoré P, Schwei J, Rogers SD, et al. Cellular and neurochemical remodeling of the spinal cord in bone cancer pain. Prog Brain Res. 2000;129:389–397.
   PubMedGoogle Scholar
• Sabino MA, Mantyh PW. Pathophysiology of bone cancer pain. J Support Oncol. 2005;3(1):15–24.
   PubMedGoogle Scholar
• Mantyh PW. The neurobiology of skeletal pain. Eur J Neurosci. 2014;39(3):508–519.
   PubMed Web of Science ®Google Scholar
• Jimenez-Andrade JM, Mantyh WG, Bloom AP, et al. A phenotypically restricted set of primary afferent nerve fibers innervate the bone versus skin: therapeutic opportunity for treating skeletal pain. Bone. 2010;46(2):306–313.
   PubMed Web of Science ®Google Scholar
• Jimenez-Andrade JM, Bloom AP, Stake JI, et al. Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain. J Neurosci. 2010;30(44):14649–14656.
   PubMed Web of Science ®Google Scholar
• Mantyh WG, Jimenez-Andrade JM, Stake JI, et al. Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience. 2010;171(2):588–598.
   PubMed Web of Science ®Google Scholar
• Yoneda T, Hiasa M, Nagata Y, et al. Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain. Biochim Biophys Acta. 2015;1848(10 Pt B):2677–2684.
   PubMed Web of Science ®Google Scholar
• Cherry JD, Olschowka JA, O’Banion MK. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation. 2014;11:98.
   PubMed Web of Science ®Google Scholar
• Furman JL, Norris CM. Calcineurin and glial signaling: neuroinflammation and beyond. J Neuroinflammation. 2014;11:158.
   PubMed Web of Science ®Google Scholar
• Hu X-M, Liu Y-N, Zhang H-L, et al. CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats. J Neurochem. 2015;132(4):452–463.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li H, Li T-T, et al. Delayed activation of spinal microglia contributes to the maintenance of bone cancer pain in female Wistar rats via P2X7 receptor and IL-18. J Neurosci. 2015;35(20):7950–7963.
   PubMedGoogle Scholar
• Hu J-H, Yang J-P, Liu L, et al. Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord. Brain Res. 2012;1465:1–9.
   PubMed Web of Science ®Google Scholar
• Jin D, Yang JP, Hu JH, et al. MCP-1 stimulates spinal microglia via PI3K/Akt pathway in bone cancer pain. Brain Res. 2015;1599:158–167.
   PubMed Web of Science ®Google Scholar
• Bu H, Shu B, Gao F, et al. Spinal IFN-gamma-induced protein-10 (CXCL10) mediates metastatic breast cancer-induced bone pain by activation of microglia in rat models. Breast Cancer Res Treat. 2014;143(2):255–263.
   PubMed Web of Science ®Google Scholar
• Saijo K, Glass CK. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol. 2011;11(11):775–787.
   PubMed Web of Science ®Google Scholar
• Honore P, Rogers SD, Schwei MJ, et al. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience. 2000;98(3):585–598.
   PubMed Web of Science ®Google Scholar
• Pan J, Lin X-J, Ling Z-H, et al. Effect of down-regulation of voltage-gated sodium channel Nav1.7 on activation of astrocytes and microglia in DRG in rats with cancer pain. Asian Pac J Trop Med. 2015;8(5):405–411.
   PubMed Web of Science ®Google Scholar
• Jin X-H, Wang L-N, Zuo J-L, et al. P2X4 receptor in the dorsal horn partially contributes to brain-derived neurotrophic factor oversecretion and toll-like receptor-4 receptor activation associated with bone cancer pain. J Neurosci Res. 2014;92(12):1690–1702.
   PubMed Web of Science ®Google Scholar
• Shen W, Hu XM, Liu YN, et al. CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord. J Neuroinflammation. 2014;11:75.
   PubMed Web of Science ®Google Scholar
• Hald A, Nedergaard S, Hansen RR, et al. Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain. Eur J Pain. 2009;13(2):138–145.
   PubMed Web of Science ®Google Scholar
• Ducourneau VR, Dolique T, Hachem-Delaunay S, et al. Cancer pain is not necessarily correlated with spinal overexpression of reactive glia markers. Pain. 2014;155(2):275–291.
   PubMed Web of Science ®Google Scholar
• Liu X, Bu H, Liu C, et al. Inhibition of glial activation in rostral ventromedial medulla attenuates mechanical allodynia in a rat model of cancer-induced bone pain. J Huazhong Univ Sci Technol Med Sci. 2012;32(2):291–298.
   PubMed Web of Science ®Google Scholar
• Pevida M, González-Rodríguez S, Lastra A, et al. Involvement of spinal chemokine CCL2 in the hyperalgesia evoked by bone cancer in mice: a role for astroglia and microglia. Cell Mol Neurobiol. 2014;34(1):143–156.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhu MD, Zhang X, et al. NFkappaB-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice. J Neuroinflammation. 2014;11:38.
   PubMed Web of Science ®Google Scholar
• Friedman R. Pain at the cellular level: the role of the cytokine tumor necrosis factor-alpha. Reg Anesth Pain Med. 2000;25(2):110–112.
   PubMed Web of Science ®Google Scholar
• Waters JP, Pober JS, Bradley JR. Tumour necrosis factor and cancer. J Pathol. 2013;230(3):241–248.
   PubMed Web of Science ®Google Scholar
• Wacnik PW, Eikmeier LJ, Simone DA, et al. Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice. Neuroscience. 2005;132(2):479–491.
   PubMed Web of Science ®Google Scholar
• Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer. 2002;2(6):420–430.
   PubMed Web of Science ®Google Scholar
• Yao M, Chang X-Y, Chu Y-X, et al. Antiallodynic effects of propentofylline elicited by interrupting spinal glial function in a rat model of bone cancer pain. J Neurosci Res. 2011;89(11):1877–1886.
   PubMed Web of Science ®Google Scholar
• Hu S, Mao-Ying Q-L, Wang J, et al. Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines. J Neuroinflammation. 2012;9:278.
   PubMed Web of Science ®Google Scholar
• Mao-Ying QL, Wang XW, Yang CJ, et al. Robust spinal neuroinflammation mediates mechanical allodynia in Walker 256 induced bone cancer rats. Mol Brain. 2012;5:16.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhang H, Liu S-B, et al. Spinal interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice. Neuroscience. 2013;253:172–182.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang X. Epigallocatechin-3-gallate attenuates bone cancer pain involving decreasing spinal tumor necrosis factor-alpha expression in a mouse model. Int Immunopharmacol. 2015;29(2):818–823.
   PubMed Web of Science ®Google Scholar
• Gu X, Zheng Y, Ren B, et al. Intraperitoneal injection of thalidomide attenuates bone cancer pain and decreases spinal tumor necrosis factor-alpha expression in a mouse model. Mol Pain. 2010;6:64.
   PubMed Web of Science ®Google Scholar
• Kaan TK, Yip PK, Patel S, et al. Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in rats. Brain. 2010;133(9):2549–2564.
   PubMed Web of Science ®Google Scholar
• Wu JX, Xu MY, Miao XR, et al. Functional up-regulation of P2X3 receptors in dorsal root ganglion in a rat model of bone cancer pain. Eur J Pain. 2012;16(10):1378–1388.
   PubMed Web of Science ®Google Scholar
• Huang ZX, Lu ZJ, Ma WQ, et al. Involvement of RVM-expressed P2X7 receptor in bone cancer pain: mechanism of descending facilitation. Pain. 2014;155(4):783–791.
   PubMed Web of Science ®Google Scholar
• Sun R-Q, Tu Y-J, Lawand NB, et al. Calcitonin gene-related peptide receptor activation produces PKA- and PKC-dependent mechanical hyperalgesia and central sensitization. J Neurophysiol. 2004;92(5):2859–2866.
   PubMed Web of Science ®Google Scholar
• Bird GC, Han JS, Fu Y, et al. Pain-related synaptic plasticity in spinal dorsal horn neurons: role of CGRP. Mol Pain. 2006;2:31.
   PubMed Web of Science ®Google Scholar
• Neugebauer V, Rümenapp P, Schaible HG. Calcitonin gene-related peptide is involved in the spinal processing of mechanosensory input from the rat’s knee joint and in the generation and maintenance of hyperexcitability of dorsal horn-neurons during development of acute inflammation. Neuroscience. 1996;71(4):1095–1109.
   PubMed Web of Science ®Google Scholar
• Hansen RR, Vacca V, Pitcher T, et al. Role of extracellular calcitonin gene-related peptide in spinal cord mechanisms of cancer-induced bone pain. Pain. 2016;157(3):666–676.
   PubMed Web of Science ®Google Scholar
• Lu C, Shi L, Sun B, et al. A single intrathecal or intraperitoneal injection of CB2 receptor agonist attenuates bone cancer pain and induces a time-dependent modification of GRK2. Cell Mol Neurobiol. 2016. [Epub ahead of print].
   Google Scholar
• Roger T, David J, Glauser MP, et al. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature. 2001;414(6866):920–924.
   PubMed Web of Science ®Google Scholar
• Lan LS, Ping YJ, Na WL, et al. Down-regulation of Toll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model. Mol Pain. 2010;6:2.
   PubMed Web of Science ®Google Scholar
• Liu S, Yang J, Wang L, et al. Tibia tumor-induced cancer pain involves spinal p38 mitogen-activated protein kinase activation via TLR4-dependent mechanisms. Brain Res. 2010;1346:213–223.
   PubMed Web of Science ®Google Scholar
• Li X, Wang X-W, Feng X-M, et al. Stage-dependent anti-allodynic effects of intrathecal Toll-like receptor 4 antagonists in a rat model of cancer induced bone pain. J Physiol Sci. 2013;63(3):203–209.
   PubMed Web of Science ®Google Scholar
• Liu S, Liu Y-P, Song WB, et al. EphrinB-EphB receptor signaling contributes to bone cancer pain via Toll-like receptor and proinflammatory cytokines in rat spinal cord. Pain. 2013;154(12):2823–2835.
   PubMed Web of Science ®Google Scholar
• Guan X-H, Fu Q-C, Shi D, et al. Activation of spinal chemokine receptor CXCR3 mediates bone cancer pain through an Akt-ERK crosstalk pathway in rats. Exp Neurol. 2015;263:39–49.
   PubMed Web of Science ®Google Scholar
• Yin Q, Cheng W, Cheng M-Y, et al. Intrathecal injection of anti-CX3CR1 neutralizing antibody delayed and attenuated pain facilitation in rat tibial bone cancer pain model. Behav Pharmacol. 2010;21(7):595–601.
   PubMed Web of Science ®Google Scholar
• Cheng W, Zhao Y, Liu H, et al. Resveratrol attenuates bone cancer pain through the inhibition of spinal glial activation and CX3CR1 upregulation. Fundam Clin Pharmacol. 2014;28(6):661–670.
   PubMed Web of Science ®Google Scholar
• Guan X, Fu Q, Xiong B, et al. Activation of PI3Kgamma/Akt pathway mediates bone cancer pain in rats. J Neurochem. 2015;134(3):590–600.
   PubMed Web of Science ®Google Scholar
• Bao Y, Hou W, Liu R, et al. PAR2-mediated upregulation of BDNF contributes to central sensitization in bone cancer pain. Mol Pain. 2014;10:28.
   PubMed Web of Science ®Google Scholar
• Zhou Y-L, Jiang G-Q, Wei J, et al. Enhanced binding capability of nuclear factor-kappaB with demethylated P2X3 receptor gene contributes to cancer pain in rats. Pain. 2015;156(10):1892–1905.
   PubMed Web of Science ®Google Scholar
• Svensson CI, Medicherla S, Malkmus S, et al. Role of p38 mitogen activated protein kinase in a model of osteosarcoma-induced pain. Pharmacol Biochem Behav. 2008;90(4):664–675.
   PubMed Web of Science ®Google Scholar
• Sukhtankar D, Okun A, Chandramouli A, et al. Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain. Mol Pain. 2011;7:81.
   PubMed Web of Science ®Google Scholar
• Han Y, Li Y, Xiao X, et al. Formaldehyde up-regulates TRPV1 through MAPK and PI3K signaling pathways in a rat model of bone cancer pain. Neurosci Bull. 2012;28(2):165–172.
   PubMed Web of Science ®Google Scholar
• Wang L-N, Yao M, Yang J-P, et al. Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord. Mol Pain. 2011;7:48.
   PubMed Web of Science ®Google Scholar
• Wang X-W, Li T-T, Zhao J, et al. Extracellular signal-regulated kinase activation in spinal astrocytes and microglia contributes to cancer-induced bone pain in rats. Neuroscience. 2012;217:172–181.
   PubMed Web of Science ®Google Scholar
• Guedon JM, Longo G, Majuta LA, et al. Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain. Pain. 2016;157(6):1239–1247.
   PubMed Web of Science ®Google Scholar
• Schmidt BL. The neurobiology of cancer pain. J Oral Maxillofac Surg. 2015;73(12 Suppl):S132–S135.
   PubMed Web of Science ®Google Scholar
• Sawada M, Sawada H, Nagatsu T. Effects of aging on neuroprotective and neurotoxic properties of microglia in neurodegenerative diseases. Neurodegener Dis. 2008;5(3–4):254–256.
   PubMed Web of Science ®Google Scholar
• Hauwel M, Furon E, Canova C, et al. Innate (inherent) control of brain infection, brain inflammation and brain repair: the role of microglia, astrocytes, “protective” glial stem cells and stromal ependymal cells. Brain Res Brain Res Rev. 2005;48(2):220–233.
   PubMedGoogle Scholar
• Cohen SP, White RL, Kurihara C, et al. Epidural steroids, etanercept, or saline in subacute sciatica: a multicenter, randomized trial. Ann Intern Med. 2012;156(8):551–559.
   PubMed Web of Science ®Google Scholar
• Ohtori S, Miyagi M, Eguchi Y, et al. Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica. Eur Spine J. 2012;21(10):2079–2084.
   PubMed Web of Science ®Google Scholar
• Cohen SP, Wenzell D, Hurley RW, et al. A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy. Anesthesiology. 2007;107(1):99–105.
   PubMed Web of Science ®Google Scholar
• Cohen SP, Galvagno SM, Plunkett A, et al. A multicenter, randomized, controlled study evaluating preventive etanercept on postoperative pain after inguinal hernia repair. Anesth Analg. 2013;116(2):455–462.
   PubMed Web of Science ®Google Scholar
• Sainoh T, Orita S, Miyagi M, et al. Single intradiscal injection of the interleukin-6 receptor antibody tocilizumab provides short-term relief of discogenic low back pain; prospective comparative cohort study. J Orthop Sci. 2016;21(1):2–6.
   PubMed Web of Science ®Google Scholar
• Landry RP, Jacobs VL, Romero-Sandoval EA, et al. Propentofylline, a CNS glial modulator does not decrease pain in post-herpetic neuralgia patients: in vitro evidence for differential responses in human and rodent microglia and macrophages. Exp Neurol. 2012;234(2):340–350.
   PubMed Web of Science ®Google Scholar
• Kalliomäki J, Attal N, Jonzon B, et al. A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia. Pain. 2013;154(5):761–767.
   PubMed Web of Science ®Google Scholar
• Martinez V, Szekely B, Lemarié J, et al. The efficacy of a glial inhibitor, minocycline, for preventing persistent pain after lumbar discectomy: a randomized, double-blind, controlled study. Pain. 2013;154(8):1197–1203.
   PubMed Web of Science ®Google Scholar
• Ostenfeld T, Krishen A, Lai RY, et al. Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study. Eur J Pain. 2013;17(6):844–857.
   PubMed Web of Science ®Google Scholar
• Ostenfeld T, Krishen A, Lai RY, et al. A randomized, placebo-controlled trial of the analgesic efficacy and safety of the p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain from lumbosacral radiculopathy. Clin J Pain. 2015;31(4):283–293.
   PubMed Web of Science ®Google Scholar
• Tiwari V, Guan Y, Raja SN. Modulating the delicate glial-neuronal interactions in neuropathic pain: promises and potential caveats. Neurosci Biobehav Rev. 2014;45:19–27.
   PubMed Web of Science ®Google Scholar
• Tatsumi E, Yamanaka H, Kobayashi K, et al. RhoA/ROCK pathway mediates p38 MAPK activation and morphological changes downstream of P2Y12/13 receptors in spinal microglia in neuropathic pain. Glia. 2015;63(2):216–228.
   PubMed Web of Science ®Google Scholar
• Tang J, Zhu C, Li Z-H, et al. Inhibition of the spinal astrocytic JNK/MCP-1 pathway activation correlates with the analgesic effects of tanshinone IIA sulfonate in neuropathic pain. J Neuroinflammation. 2015;12:57.
   PubMed Web of Science ®Google Scholar
• Willis CL, Brooks TA, Davis TP. Chronic inflammatory pain and the neurovascular unit: a central role for glia in maintaining BBB integrity? Curr Pharm Des. 2008;14(16):1625–1643.
   PubMed Web of Science ®Google Scholar
• Feldman-Goriachnik R, Belzer V, Hanani M. Systemic inflammation activates satellite glial cells in the mouse nodose ganglion and alters their functions. Glia. 2015;63:2121–2132.
   Web of Science ®Google Scholar
• Huang CY, Chen YL, Li AH, et al. Minocycline, a microglial inhibitor, blocks spinal CCL2-induced heat hyperalgesia and augmentation of glutamatergic transmission in substantia gelatinosa neurons. J Neuroinflammation. 2014;11:7.
   PubMed Web of Science ®Google Scholar
• Lu C-L. Spinal microglia: a potential target in the treatment of chronic visceral pain. J Chin Med Assoc. 2014;77(1):3–9.
   PubMed Web of Science ®Google Scholar
• Demir IE, Tieftrunk E, Schorn S, et al. Activated Schwann cells in pancreatic cancer are linked to analgesia via suppression of spinal astroglia and microglia. Gut. 2016;65(6):1001–1014.
   PubMed Web of Science ®Google Scholar
• Tramullas M, Finger BC, Moloney RD, et al. Toll-like receptor 4 regulates chronic stress-induced visceral pain in mice. Biol Psychiatry. 2014;76(4):340–348.
   PubMed Web of Science ®Google Scholar
• Shen N, Mo L-Q, Hu F, et al. A novel role of spinal astrocytic connexin 43: mediating morphine antinociceptive tolerance by activation of NMDA receptors and inhibition of glutamate transporter-1 in rats. CNS Neurosci Ther. 2014;20(8):728–736.
   PubMed Web of Science ®Google Scholar
• Li W, Li Y, Zhu S, et al. Rosuvastatin attenuated the existing morphine tolerance in rats with L5 spinal nerve transection through inhibiting activation of astrocytes and phosphorylation of ERK42/44. Neurosci Lett. 2015;584:314–319.
   PubMed Web of Science ®Google Scholar
• Wen Y-R, Tan P-H, Cheng J-K, et al. Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance. J Formos Med Assoc. 2011;110(8):487–494.
   PubMed Web of Science ®Google Scholar
• Shiratori-Hayashi M, Koga K, Tozaki-Saitoh H, et al. STAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch. Nat Med. 2015;21(8):927–931.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dun SL, Chen YH, et al. Scratching activates microglia in the mouse spinal cord. J Neurosci Res. 2015;93(3):466–474.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yan J, Hu R, et al. Microglia are involved in pruritus induced by DNFB via the CX3CR1/p38 MAPK pathway. Cell Physiol Biochem. 2015;35(3):1023–1033.
   PubMed Web of Science ®Google Scholar
• Almad AA, Maragakis NJ. Glia: an emerging target for neurological disease therapy. Stem Cell Res Ther. 2012;3(5):37.
   PubMed Web of Science ®Google Scholar
• Li M, Mei W, Wang P, et al. Propofol reduces early post-operative pain after gynecological laparoscopy. Acta Anaesthesiol Scand. 2012;56(3):368–375.
   PubMed Web of Science ®Google Scholar
• Xu B, Guan XH, Yu JX, et al. Activation of spinal phosphatidylinositol 3-kinase/protein kinase B mediates pain behavior induced by plantar incision in mice. Exp Neurol. 2014;255:71–82.
   PubMed Web of Science ®Google Scholar
• Shi Y, Gelman BB, Lisinicchia JG, et al. Chronic-pain-associated astrocytic reaction in the spinal cord dorsal horn of human immunodeficiency virus-infected patients. J Neurosci. 2012;32(32):10833–10840.
   PubMed Web of Science ®Google Scholar
• Loggia ML, Chonde DB, Akeju O, et al. Evidence for brain glial activation in chronic pain patients. Brain. 2015;138(Pt 3):604–615.
   PubMed Web of Science ®Google Scholar